TLC-Act: A Novel Tool for Managing Drug Interactions.

IF 0.6 Q4 PHARMACOLOGY & PHARMACY CANADIAN JOURNAL OF HOSPITAL PHARMACY Pub Date : 2022-01-01 DOI:10.4212/cjhp.3171
Casara Hong, Michael Legal, Harkaryn Bagri, Louise Lau, Karen Dahri
{"title":"TLC-Act: A Novel Tool for Managing Drug Interactions.","authors":"Casara Hong,&nbsp;Michael Legal,&nbsp;Harkaryn Bagri,&nbsp;Louise Lau,&nbsp;Karen Dahri","doi":"10.4212/cjhp.3171","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical decision support systems (CDSS) are used by pharmacists to assist in managing drug-drug interactions (DDIs). However, previous research suggests that such systems may perform suboptimally in providing clinically relevant information in practice.</p><p><strong>Objectives: </strong>The primary objective of this study was to develop a novel DDI management tool to reflect the clinical thought process that a pharmacist uses when assessing a DDI. The secondary objective was to investigate practitioners' perceptions of this tool.</p><p><strong>Methods: </strong>This study was conducted in 3 phases: development of the DDI management tool, implementation of the tool in clinical practice, and collection of practitioners' opinions of the tool through an online qualitative survey (although because of circumstances related to the COVID-19 pandemic, the study population for the survey phase included only pharmacy residents). A comprehensive literature search and analysis by an expert panel provided underlying context for the DDI management tool. The tool was validated through simulation against a known list of DDIs before implementation into practice by hospital pharmacists and pharmacy residents. Participating pharmacy residents were invited to provide feedback on the tool. Survey results were analyzed using descriptive statistics.</p><p><strong>Results: </strong>The novel tool that was developed in this study (called TLC-Act) consisted of components important to a pharmacist when assessing a DDI, including the duration of concomitant use of the interacting medications and patient-specific risk factors. Study participants implemented the tool in clinical practice for a total of 6 weeks. Of the 28 pharmacy residents surveyed, 15 (54%) submitted a response, of whom 11 (73%) found the TLC-Act tool to be slightly more useful for assessing a DDI than usual care with the CDSS alone.</p><p><strong>Conclusions: </strong>The TLC-Act tool maps out a pharmacist's clinical thought process when assessing a DDI in practice. This novel tool may be more useful than a CDSS alone for managing DDIs, as it takes into account other important factors pertinent to the assessment of a DDI.</p>","PeriodicalId":51646,"journal":{"name":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","volume":"75 3","pages":"193-200"},"PeriodicalIF":0.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245403/pdf/cjhp-75-193.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CANADIAN JOURNAL OF HOSPITAL PHARMACY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4212/cjhp.3171","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Clinical decision support systems (CDSS) are used by pharmacists to assist in managing drug-drug interactions (DDIs). However, previous research suggests that such systems may perform suboptimally in providing clinically relevant information in practice.

Objectives: The primary objective of this study was to develop a novel DDI management tool to reflect the clinical thought process that a pharmacist uses when assessing a DDI. The secondary objective was to investigate practitioners' perceptions of this tool.

Methods: This study was conducted in 3 phases: development of the DDI management tool, implementation of the tool in clinical practice, and collection of practitioners' opinions of the tool through an online qualitative survey (although because of circumstances related to the COVID-19 pandemic, the study population for the survey phase included only pharmacy residents). A comprehensive literature search and analysis by an expert panel provided underlying context for the DDI management tool. The tool was validated through simulation against a known list of DDIs before implementation into practice by hospital pharmacists and pharmacy residents. Participating pharmacy residents were invited to provide feedback on the tool. Survey results were analyzed using descriptive statistics.

Results: The novel tool that was developed in this study (called TLC-Act) consisted of components important to a pharmacist when assessing a DDI, including the duration of concomitant use of the interacting medications and patient-specific risk factors. Study participants implemented the tool in clinical practice for a total of 6 weeks. Of the 28 pharmacy residents surveyed, 15 (54%) submitted a response, of whom 11 (73%) found the TLC-Act tool to be slightly more useful for assessing a DDI than usual care with the CDSS alone.

Conclusions: The TLC-Act tool maps out a pharmacist's clinical thought process when assessing a DDI in practice. This novel tool may be more useful than a CDSS alone for managing DDIs, as it takes into account other important factors pertinent to the assessment of a DDI.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
TLC-Act:管理药物相互作用的新工具。
背景:临床决策支持系统(CDSS)被药剂师用来协助管理药物-药物相互作用(ddi)。然而,先前的研究表明,在实践中,这种系统在提供临床相关信息方面可能表现不佳。目的:本研究的主要目的是开发一种新的DDI管理工具,以反映药剂师在评估DDI时使用的临床思维过程。次要目标是调查从业者对该工具的看法。方法:本研究分3个阶段进行:开发DDI管理工具,在临床实践中实施该工具,通过在线定性调查收集从业者对该工具的意见(尽管由于与COVID-19大流行有关的情况,调查阶段的研究人群仅包括药房居民)。专家小组进行了全面的文献检索和分析,为DDI管理工具提供了基础背景。在医院药剂师和药房居民实施之前,通过对已知ddi列表的模拟验证了该工具。参与的药房居民被邀请对该工具提供反馈。对调查结果进行描述性统计分析。结果:在这项研究中开发的新工具(称为TLC-Act)由药剂师在评估DDI时重要的组成部分组成,包括同时使用相互作用药物的持续时间和患者特定的风险因素。研究参与者在临床实践中使用该工具共6周。在接受调查的28名药房居民中,15名(54%)提交了回复,其中11名(73%)发现TLC-Act工具在评估DDI方面比单独使用CDSS的常规护理更有用。结论:TLC-Act工具在实践中评估DDI时绘制了药剂师的临床思维过程。对于管理DDI,这个新工具可能比单独的CDSS更有用,因为它考虑了与评估DDI相关的其他重要因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CANADIAN JOURNAL OF HOSPITAL PHARMACY
CANADIAN JOURNAL OF HOSPITAL PHARMACY PHARMACOLOGY & PHARMACY-
CiteScore
1.10
自引率
0.00%
发文量
64
期刊介绍: The CJHP is an academic journal that focuses on how pharmacists in hospitals and other collaborative health care settings optimize safe and effective drug use for patients in Canada and throughout the world. The aim of the CJHP is to be a respected international publication serving as a major venue for dissemination of information related to patient-centred pharmacy practice in hospitals and other collaborative health care settings in Canada and throughout the world.
期刊最新文献
Burnout: A Real Problem in Need of Multifaceted Solutions. Considering Sex and Gender in Therapeutics throughout the Product Life Cycle: A Narrative Review and Case Study of Gilteritinib. Vancomycin Therapeutic Drug Monitoring: A Cross-Sectional Survey of Canadian Hospitals. Impact of Pharmacist-Provided Education Using New Information Sheets on Activation in Patients Treated with Oral Antineoplastic Drugs (IMPACT-OAD Project). Cap sur un avenir durable.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1